NOT FOR DISTRIBUTION
Header cover image

Rossmax International

Market Cap

NT$1.8b

Last Updated

2021/09/16 08:32 UTC

Data Sources

Company Financials

Executive Summary

Rossmax International Ltd. develops and supplies healthcare products and solutions in Taiwan. More Details


Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

Share Price & News

How has Rossmax International's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 4121 is more volatile than 75% of TW stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 4121's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of TW stocks.


Market Performance


7 Day Return

-4.1%

4121

0.4%

TW Medical Equipment

0.2%

TW Market


1 Year Return

15.3%

4121

7.0%

TW Medical Equipment

34.2%

TW Market

Return vs Industry: 4121 exceeded the TW Medical Equipment industry which returned 7% over the past year.

Return vs Market: 4121 underperformed the TW Market which returned 34.2% over the past year.


Shareholder returns

4121IndustryMarket
7 Day-4.1%0.4%0.2%
30 Day-6.8%3.0%4.2%
90 Day-29.1%-7.4%0.2%
1 Year21.2%15.3%10.0%7.0%38.1%34.2%
3 Year82.3%70.2%23.0%12.6%78.2%59.9%
5 Year76.3%61.1%8.9%-6.2%122.9%85.5%

Long-Term Price Volatility Vs. Market

How volatile is Rossmax International's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Rossmax International undervalued compared to its fair value and its price relative to the market?

18.4%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 4121 (NT$21.1) is trading below our estimate of fair value (NT$25.86)

Significantly Below Fair Value: 4121 is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: 4121 is good value based on its PE Ratio (9.7x) compared to the TW Medical Equipment industry average (22.8x).

PE vs Market: 4121 is good value based on its PE Ratio (9.7x) compared to the TW market (16.4x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 4121's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 4121 is good value based on its PB Ratio (1.2x) compared to the TW Medical Equipment industry average (2.1x).


Future Growth

How is Rossmax International forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.4%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Rossmax International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Rossmax International performed over the past 5 years?

52.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 4121 has a high level of non-cash earnings.

Growing Profit Margin: 4121's current net profit margins (4.6%) are higher than last year (1.9%).


Past Earnings Growth Analysis

Earnings Trend: 4121 has become profitable over the past 5 years, growing earnings by 52.6% per year.

Accelerating Growth: 4121's earnings growth over the past year (202%) exceeds its 5-year average (52.6% per year).

Earnings vs Industry: 4121 earnings growth over the past year (202%) exceeded the Medical Equipment industry 9.5%.


Return on Equity

High ROE: 4121's Return on Equity (11.2%) is considered low.


Financial Health

How is Rossmax International's financial position?


Financial Position Analysis

Short Term Liabilities: 4121's short term assets (NT$2.2B) exceed its short term liabilities (NT$1.1B).

Long Term Liabilities: 4121's short term assets (NT$2.2B) exceed its long term liabilities (NT$837.8M).


Debt to Equity History and Analysis

Debt Level: 4121's debt to equity ratio (18.8%) is considered satisfactory.

Reducing Debt: 4121's debt to equity ratio has reduced from 44.2% to 18.8% over the past 5 years.

Debt Coverage: 4121's debt is well covered by operating cash flow (21.6%).

Interest Coverage: 4121's interest payments on its debt are well covered by EBIT (12.9x coverage).


Balance Sheet


Dividend

What is Rossmax International current dividend yield, its reliability and sustainability?

5.69%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 4121's dividend (5.69%) is higher than the bottom 25% of dividend payers in the TW market (1.94%).

High Dividend: 4121's dividend (5.69%) is in the top 25% of dividend payers in the TW market (5.26%)


Stability and Growth of Payments

Stable Dividend: 4121's dividend payments have been volatile in the past 10 years.

Growing Dividend: 4121's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (47.4%), 4121's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.3yrs

Average board tenure


CEO

Chih-Ping Liu

no data

Tenure

Mr. Chih-Ping Liu serves as Chairman and General Manager of Rossmax International Ltd. and has been its Director since December 13, 1988. Mr. Liu serves as Chairman of ROSSMAX medical electronics Shanghai...


Board Members

Experienced Board: 4121's board of directors are considered experienced (3.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.8%.


Top Shareholders

Company Information

Rossmax International Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Rossmax International Ltd.
  • Ticker: 4121
  • Exchange: TPEX
  • Founded: 1988
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: NT$1.775b
  • Shares outstanding: 84.14m
  • Website: https://www.rossmax.com

Location

  • Rossmax International Ltd.
  • No. 189, Kang Chien Road
  • 12th Floor
  • Taipei
  • 114
  • Taiwan

Listings


Biography

Rossmax International Ltd. develops and supplies healthcare products and solutions in Taiwan. The company offers activity monitor, a device for monitoring and tracking fitness-related metrics, such as dist...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/16 08:32
End of Day Share Price2021/09/15 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.